Shasun Pharmaceuticals Limited: corporate announcements

123 records, the earliest from 4 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

Bulk & block deals Corporate actions Announcements Dividends Board meetings Insider trading & SAST Download CSV

123 shown.

Date	Category	Subject
17 Nov 2015 08:35	Updates	Shasun Pharmaceuticals Limited has informed the Exchange that there was a fire accident at New production block during trial & commissioning in Cuddalore API facility on November 16, 2015. Company regrets to inform the sad demise of one worker in the accident. One more injured employee has been admitted in the hospital for treatment. The Company has informed the government authorities about the same and investigating the root cause of the accident.The damage on account of fire is being assessed for which the company has adequate insurance cover. However there will not be any significant loss of revenue or production due to the above accident.
16 Nov 2015 05:35	Press Release	Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 16, 2015 titled "Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets".
6 Nov 2015 13:27	Record Date	Strides Arcolab Limited has informed the Exchange that as approved by the Board of Directors of the Strides Acrolab Limited by a resolution passed on November 05, 2015, has fixed Record Date as November 19, 2015 for the purpose of determining the names of the shareholders of Shasun Pharmaceuticals Limited who will be entitled to shares in the Strides Acrolab Limited (as consideration under the Scheme of the Amalgamation), in the exchange ratio of 5 (five) equity shares of Rs. 10/- each of Strides for every 16 (sixteen) equity shares of Rs. 2/- each held in the Shasun Pharmaceuticals Limited.
27 Oct 2015 08:43	Press Release	Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 27, 2015 titled "Shasun Pharmaceuticals Ltd announces strong Q2 FY 16 results".
27 Oct 2015 08:36	Financial Result Updates	Shasun Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2015.
19 Oct 2015 09:18	Trading Window	Shasun Pharmaceuticals Limited has informed the Exchange that as per the provisions of the Company's Code for Prevention of Insider Trading, the trading window for designated employees of the Company closed from September 10, 2015 to October 29, 2015 (both days inclusive).
13 Oct 2015 12:23	Outcome of Board Meeting	Shasun Pharmaceuticals Limited has informed the Exchange that the Board at its meeting held October 13, 2015 has allotted 31,600 equity shares of the face value of Rs.2 each under the ESOP Scheme.The paid up share capital of the Company has increased from Rs.13,44,47,704/ - consisting of 6,72,23,852 equity shares to Rs.13,45,10,904/- consisting of 6,72,55,452 equity shares.
25 Aug 2015 10:40	Annual General Meeting Updates	Shasun Pharmaceuticals Limited has submitted to the Exchange a copy of Minutes of Annual General Meeting of the Company held on August 12, 2015.
14 Aug 2015 06:12	Disclosure of Voting Pattern - Clause 35A	Shasun Pharmaceuticals Limited has submitted to the Exchange a copy of voting results of Annual General Meeting of the Company held on August 12, 2015, along with a copy of Scrutinizer's Report pursuant to Clause 35A of the Listing Agreement.
30 Jul 2015 07:45	Dividend	Shasun Pharmaceuticals Limited has informed the Exchange that The Board at its meeting held on July 30, 2015 has approved the following: 1. Interim Dividend of 50% (Rs. 1 per share) on the equity shares of face value of Rs.2/- each.

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.